Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliers
advertisement
advertisement
advertisement
advertisement
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
LIMS Launchpad Webinar Series - Episode #4 – The Vendor Interaction
-
Monitoring the Food Production Environment Using Real-time Total Viable Counts
-
Rapid Methods Europe (RME) 2025
-
PDA Pharmaceutical Microbiology Conference 2025
-
Lab Innovations
-
Engineering Microbes and Microbial Communities for Sustainable Bioproduction
-
The Future of Sterility Testing: One-Day Results with Advanced RT-rt PCR Technology
-
AMP2025
-
Growth Direct® Day 2025
-
MEDICA 2025
